Summary
This review highlights some of the caveats assessing the available clinical data base for determining the efficacy, safety, and cost of laser systems used to treat benign prostatic hyperplasia. Many new minimally invasive devices have recently been advanced in spite of the limited data base and the lack of properly designed clinical trials. There have been many claims regarding the effectiveness of laser prostatectomy based on the available clinical data. Some important general considerations for interpreting the clinical data base, critically analyzing the study design, and interpreting the data are discussed. Similarly, many claims have been made with respect to the cost of laser prostatectomy; however, insufficient objective data are available for clear determinations of cost. Some of the pertinent issues involved in the cost assessment of laser prostatectomy are also highlighted. It is hoped that this review will provide the reader with some additional insight into the critical assessment of the quality of studies that evaluate the safety, efficacy, and cost of new devices such as the laser.
Similar content being viewed by others
References
Lepor H, Auerbach S, Puras-Baez A, Narayan P, Soloway M, Lowe F, Moon T, Leifer G, Madsen P (1992) A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol 148:1467–1474
Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughn ED, Pappas F, Taylor A, Binkowitz B, Ng J (1992) The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 327:1185–1191
Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, Writing Committee (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 141:243–247
Dixon C, Machi G, Theune C, Lepor H (1993) A prospective, double-blind, randomized study comparing the safety, efficacy and cost of laser ablation of the prostate and transurethral prostatectomy for the treatment of BPH (abstract). J Urol 151:229A, 7A
Leach GE, Dmochowski R, Kumaresan G, Broderick GS, Wein AJ, Cowles R, Kabalin JN, Gill HS (1994) Visual laser assisted prostatectomy (VLAP) using Urolase right-angle fiber: multicenter 60 Watt protocol (abstract). J Urol 151:228A, 4A
Costello AJ, Crowe HR (1994) A single institution experience of reflecting laser fibre prostatectomy over four years (abstract). J Urol 151:229A, 6A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dixon, C.M. Evaluating the efficacy, safety, and cost of lasers for the treatment of benign prostatic hyperplasia. World J Urol 13, 130–133 (1995). https://doi.org/10.1007/BF00183630
Issue Date:
DOI: https://doi.org/10.1007/BF00183630